CT scan alert
This article was originally published in The Gray Sheet
Executive Summary
Computed tomography scans may interfere with certain electronic medical devices, including pacemakers, defibrillators, neurostimulators and implanted or external drug infusion pumps, FDA warns in a July 14 preliminary 1public health notification. Interference from CT scans may cause unintended shocks, insulin pump malfunction and changes in pacemaker pacing, FDA notes, though no deaths have been reported. When possible, operators should move external devices out of CT scan range, temporarily shut devices off or otherwise minimize X-ray exposure, FDA recommends. The agency's medical imaging systems assessment lab says it is doing preliminary research to better understand CT/implanted device interaction issues
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.